Anti-RSV Therapeutic Antibody (Palivizumab)
Recombinant monoclonal antibody to Human RSV. Palivizumab is a monoclonal antibody produced by recombinant DNA technology. It is used in the prevention of respiratory syncytial virus (RSV) infections. It is recommended for infants that are high-risk because of prematurity or other medical problems such as congenital heart disease. Palivizumab is a humanized monoclonal antibody (IgG) directed against an epitope in the A antigenic site of the F protein of RSV.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-009 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | RSV |
| Species Reactivity | RSV |
| Type | IgG1 - kappa |
| Applications | IF, IP, Neut, FuncS, ELISA, FC, WB |
| Storage | Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage. |